Share on LinkedInShare on LinkedIn

ARTICLE · 17 APRIL 2025

Update On Status Of Rescheduling Cannabis From Schedule I To Schedule III Under The U.S. Controlled Substances Act

There have been years of debate as to whether or not cannabis should be classified under Schedule I (high potential for abuse, no currently accepted medical use in treatment in the United States...

United StatesCannabis & Hemp

There have been years of debate as to whether or not cannabis should be classified under Schedule I (high potential for abuse, no currently accepted medical use in treatment in the United States and a lack of accepted safety for use under medical supervision) or Schedule III (a potential for abuse less than those in Schedules I and II, have a currently accepted medical use and abuse may lead to moderate or low physical dependence or high psychological dependence) of the US Controlled Substances Act.

Although the U.S. Department of Health and Human Services determined through scientific and medical evaluation that cannabis has currently accepted medical use in the U.S. and recommended in August 2023 that it be rescheduled, former DEA Administrator Anne Milgram did not sign a notice of proposed rulemaking for that recommendation—a document typically signed by someone in her position.

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

See more popular content from